Thyroid Physiology and Disease
Thyroid hormone synthesis: iodine (absorbed as I−; oxidised by TPO/H2O2 to I2; organified onto thyroglobulin Tyr residues forming MIT/DIT; coupled to T3/T4) requires adequate iodine (~150 μg/day), selenium (DIO1/2/3 for T4↔T3 interconversion), iron (TPO haem cofactor), and antioxidant protection (H2O2 generated by DUOX1/2 for iodination also oxidises TPO). Hypothyroidism (TSH >4 mU/L; T4/T3 deficiency; affects ~5% adults; overt) causes: fatigue, cold intolerance, weight gain, bradycardia, hair loss, cognitive slowing. Hashimoto’s thyroiditis (autoimmune; TPO-Ab+; anti-thyroglobulin Ab+; lymphocytic infiltration; Th1/Th17 dominant) is the most common cause of hypothyroidism in iodine-sufficient regions. Hyperthyroidism (TSH <0.1 mU/L; Graves’ disease: TSH-R stimulating Ab; toxic multinodular goitre) causes: anxiety, palpitations, heat intolerance, weight loss, ophthalmopathy. Selenium deficiency is well-established as a thyroid disease risk factor (Keshan-like combined Se+I deficiency; reduced GPx activity in thyroid gland allows H2O2 accumulation). Selenium supplementation (200 μg/day selenomethionine) reduces TPO-Ab titre −30–50% in Hashimoto’s RCTs.
Spirulina Mechanisms in Thyroid Function
Selenium DIO1/DIO2 T4→T3 Conversion
Circulating T3 (the biologically active hormone; 3–4× more potent than T4; binds TRα/TRβ nuclear receptors; regulates BMR, thermogenesis, cardiac output, neurological development) derives ~80% from peripheral T4 deiodination by DIO1 (liver/kidney; outer-ring 5′ deiodination; Sec active site) and DIO2 (brain/pituitary/thyroid/BAT; inner tissue T3 supply; higher T4 affinity). Se deficiency reduces DIO activity, elevating reverse T3 (rT3; metabolically inactive; inner-ring product) and impairing T3 availability. Spirulina selenomethionine provision (~2–4 μg Se per 10g; 70–90% bioavailable) supports Sec incorporation into DIO1/2, maintaining T4→T3 conversion efficiency (fT3:fT4 ratio improvement; rT3 −5–10%). While spirulina Se alone is not sufficient for therapeutic Se replacement in overt deficiency, it contributes to marginal Se status correction in borderline-deficient populations.
Thyroid Peroxidase (TPO) Antioxidant Protection
TPO (thyroid peroxidase; haem-containing glycoprotein; ~105 kDa; catalyses iodination and coupling steps of thyroid hormone synthesis) uses H2O2 generated by DUOX1/2 (dual oxidase; Ca2+-activated; membrane-associated NADPH oxidase isoforms) as the oxidant for I− activation. Excess H2O2 also oxidises TPO itself (TPO Compound II formation; inactive; requires reduction back to native enzyme). Thyroidal GPx3 (extracellular; Se-dependent; high expression in thyroid gland) scavenges excess H2O2, protecting TPO activity. Se deficiency reduces GPx3 activity, allowing H2O2 accumulation and TPO inactivation/autoantigen generation (oxidised TPO may enhance autoimmunogenicity). Spirulina Se support (+GPx3 activity) and Nrf2-driven TrxR antioxidant protection maintain optimal H2O2 balance in thyroid follicular cells: sufficient for iodination, insufficient for self-oxidative damage.
Anti-inflammatory Autoimmune Thyroiditis Modulation
Hashimoto’s thyroiditis involves Th1/Th17 cytokines (IFN-γ, IL-17, TNF-α) activating thyroid cell MHC-II and Fas/FasL apoptosis, with dendritic cell-driven TPO/Tg antigen presentation to autoreactive T cells. NF-κB in thyroid follicular cells (activated by cytokines and DAMP from oxidised TPO) upregulates CXCL10 (attracting Th1 CXCR3+ cells) and MHC-II (antigen presentation). Spirulina phycocyanin NF-κB suppression in thyroid cells reduces CXCL10 (−20–35%) and ICAM-1 (−20–30%), limiting immune cell recruitment. Polysaccharide-driven Treg expansion (−Th17 balance) may reduce autoimmune amplification. TPO-Ab titre: clinical data in hypothyroid patients show −10–25% over 3–6 months with spirulina, paralleling effect direction of selenium supplementation RCTs. Note: iodine excess from spirulina is negligible; typical spirulina iodine ~30–80 μg/10g (mostly as iodide/organic iodine; generally safe; but high-dose iodine can transiently worsen autoimmune thyroiditis via Wolff-Chaikoff effect).
Iron and TPO Haem Cofactor
TPO requires haem iron (Fe2+; incorporated as haem b; essential for both peroxidase and coupling activities). Iron deficiency reduces TPO activity (iron-deficient thyroid glands show enlarged follicular cells, impaired thyroglobulin iodination, and higher TSH for equivalent T4 production). Spirulina iron provision (1.4–2.0 mg Fe/10g; ~20–30% bioavailability from phycocyanin chelate) supports haem availability for TPO synthesis (ALAS2/ferrochelatase haem biosynthesis). In combined iron+iodine deficiency (common in sub-Saharan Africa and Southeast Asia), spirulina iron provision improves thyroid hormone synthesis more effectively than iodine alone. Serum ferritin correlation with thyroid function improvement supports the iron-TPO haem mechanism.
Clinical Outcomes in Thyroid Function
- TSH (subclinical hypothyroid): −0.3–0.8 mU/L toward normal range
- fT3:fT4 ratio: +5–10% improvement (Se-DIO support)
- TPO-Ab titre (Hashimoto’s): −10–25% at 3–6 months
- Thyroglobulin-Ab: −10–20%
- Hypothyroid symptom score: Modest improvement in subclinical/autoimmune context
Dosing and Drug Interactions
Thyroid support: 5–10g daily; do not use spirulina as replacement for levothyroxine. Levothyroxine: Spirulina iron/calcium can bind levothyroxine in gut, reducing absorption; take levothyroxine 30–60 min before spirulina or 4h apart. Antithyroid drugs (methimazole, carbimazole): Spirulina does not antagonise antithyroid mechanism; complementary antioxidant protection. Selenium supplements: Combined spirulina Se + selenium supplement may approach therapeutic dose range (200 μg/day target for Hashimoto’s); monitor total Se intake. Summary: DIO T4:T3 improved, GPx3 TPO protection, TPO-Ab −10–25%, haem Fe cofactor support; dosing 5–10g; separate from levothyroxine by 4h. NK concern: low.